Dr Sanghamitra Pati ranks No.1 among ICMR scientists featured in Stanford World's Top 2% scientists list 2026
dr sanghamitra pati
New Delhi: Dr Sanghamitra Pati, an Additional Director General at the Indian Council of Medical Research (ICMR) in New Delhi and Director of ICMR-National Institute of Health Research, has secured the top position among 22 ICMR scientists featured in the Stanford-Elsevier World's Top 2% Scientists list 2026.
Distinguished physician, laboratory scientist, and public health researcher with over 33 years of experience in the field, Dr Pati has ranked the highest among other listed ICMR scientists, with a rank of 19,407 in the assessment. She has also been ranked 357th globally in the Microbiology subfield, with Clinical Medicine listed as her primary field of research.
She has been featured in the scientific impact assessment for two consecutive years, 2024–2025 and 2025–2026.
As per the 2026 ranking details, Dr Pati has an h-index of 21 and an hm index of 7.
The Stanford University–Elsevier assessment draws on Scopus citation records available up to August 1, 2026. Researchers are evaluated using indicators including the composite citation score (c-score), h-index, and research impact, covering 22 major disciplines and 174 sub-fields.
Dr Pati played a crucial role during the critical time of the COVID-19 pandemic, in leading serosurvelience studies not only in Odisha but also in adjoining states of Chhattisgarh and Jharkhand. She was also instrumental in co-developing the first Make in Odisha rapid Antigen kit for COVID-19 diagnosis.
She began her academic journey by earning an MBBS in 1992 and an MD in 1998 from MKCG Medical College in Berhampur, Odisha, India. In 2000, she was honored with the Joint Japan/World Bank Graduate Scholarship (JJ/WBGSP), which allowed her to pursue a Master of Public Health (MPH) at the University of Maastricht in the Netherlands. She further advanced her education and achieved a PhD from the same university in 2023.
Dr. Pati’s leadership roles have been impactful, particularly in her tenure as the Director of the ICMR- National Institute of Health Research, Bhubaneswar (renamed Regional Medical Research Centre in Bhubaneswar) from August 2016 to present. In December 2024, she took on the role of Additional Director General at the Indian Council of Medical Research (ICMR) in New Delhi, continuing her significant contributions to public health research and policy.
A Distinguished Lown Scholar at Harvard School of Public Health, Boston, she has co-authored 450+ scientific publications in the peer-reviewed journals and co-authored two books on health care and a few book chapters. She serves as a reviewer for esteemed journals such as The Lancet, PLOS ONE, BMJ Open, BMC Family Practice, and is an editorial board member of the European Journal of Cancer Care and Frontiers in Public Health.
In appreciation of her extraordinary contribution to public health and research, she has been conferred with prestigious awards including Samanta Chandrasekhara Award-2018 by Odisha Bigyan Academy, Devi Award-2020 by the honourable Chief Minister, The President’s Appreciation Award-2020 by Indian Medical Association (IMA), Times Power Women Award-2021, Madhubabu Odisha Gourav Samman Award-2023, Cuttack, Biswamukti Rashtriya Swasthyasewa Samman-2023, Odisha Women Award-2023 by Ever Green Forum and Chief Minister’s Award for Excellence in Healthcare Services, Govt. of Odisha -2024 felicitated by Odisha CSR Forum-2024, Women Achievers award, Rotary, Bhubaneswar-2025 and Femina Achievers, Odisha-2025 and Indian Medical Association HQs Professors-2025. Her extraordinary contribution to Public Health and Research, instrumented in co-developing the first Make in Odisha rapid-antigen kit for Covid-19 diagnosis. Under her leadership, she recently developed an India’s first multistage malaria vaccine (AdFalciVac) against Plasmodium falciparum to prevent infection in human and reducing transmission in community and technology transferred to five Indian companies for further manufacturing, clinical trial and commercialization.
Dr. Pati is a Fellow of the National Academy of Sciences (FNASc.), India; National Academy of Medical Sciences (NAMS), India; National Academy of Sciences, India (NASI); the Fellow of the Royal College of Physicians (FRCP), London; the Fellow of the Royal College of Physicians (FRCP), Edinburgh; the Royal Society of Public Health (RSPH), UK; and the Union for International Cancer Control (UICC).
Also read- 22 ICMR Scientists feature in Stanford World's top 2% scientists list 2026
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.